1. Home
  2. GMRE vs FTRE Comparison

GMRE vs FTRE Comparison

Compare GMRE & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMRE
  • FTRE
  • Stock Information
  • Founded
  • GMRE 2011
  • FTRE 1996
  • Country
  • GMRE United States
  • FTRE United States
  • Employees
  • GMRE N/A
  • FTRE N/A
  • Industry
  • GMRE Real Estate Investment Trusts
  • FTRE Medical Specialities
  • Sector
  • GMRE Real Estate
  • FTRE Health Care
  • Exchange
  • GMRE Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • GMRE 485.5M
  • FTRE 469.0M
  • IPO Year
  • GMRE N/A
  • FTRE N/A
  • Fundamental
  • Price
  • GMRE $7.10
  • FTRE $5.04
  • Analyst Decision
  • GMRE Buy
  • FTRE Hold
  • Analyst Count
  • GMRE 3
  • FTRE 11
  • Target Price
  • GMRE $10.38
  • FTRE $16.10
  • AVG Volume (30 Days)
  • GMRE 861.2K
  • FTRE 2.8M
  • Earning Date
  • GMRE 08-05-2025
  • FTRE 08-11-2025
  • Dividend Yield
  • GMRE 11.85%
  • FTRE N/A
  • EPS Growth
  • GMRE N/A
  • FTRE N/A
  • EPS
  • GMRE 0.03
  • FTRE N/A
  • Revenue
  • GMRE $138,220,000.00
  • FTRE $2,685,600,000.00
  • Revenue This Year
  • GMRE $4.64
  • FTRE N/A
  • Revenue Next Year
  • GMRE $3.78
  • FTRE $1.36
  • P/E Ratio
  • GMRE $221.50
  • FTRE N/A
  • Revenue Growth
  • GMRE N/A
  • FTRE N/A
  • 52 Week Low
  • GMRE $6.06
  • FTRE $3.97
  • 52 Week High
  • GMRE $10.46
  • FTRE $28.41
  • Technical
  • Relative Strength Index (RSI)
  • GMRE 64.39
  • FTRE 48.27
  • Support Level
  • GMRE $7.08
  • FTRE $4.36
  • Resistance Level
  • GMRE $7.29
  • FTRE $5.31
  • Average True Range (ATR)
  • GMRE 0.22
  • FTRE 0.38
  • MACD
  • GMRE 0.10
  • FTRE -0.04
  • Stochastic Oscillator
  • GMRE 87.93
  • FTRE 51.31

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: